Experienced in Heart Block

Jorn A. Schmitt

Giessen, HE, DE 
Clinical Trials:Currently Recruiting for 1 Trial
Experienced in Heart Block
Giessen, HE, DE 
OverviewLocationsClinical Research

Overview

Jorn Schmitt practices in Giessen, Germany. Schmitt is rated as an Experienced expert by MediFind in the treatment of Heart Block. Their top areas of expertise are Ectopic Heartbeat, Heart Failure, Atrial Fibrillation, Cardiac Ablation, and Carotid Artery Surgery.

Their clinical research consists of co-authoring 48 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 3 articles in the study of Heart Block.

Locations

Giessen, HE, Germany
Other Locations
Kaiserslautern, RP 67655, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Clinical Trial of Atrial Fibrillation Patients Comparing Left Atrial Appendage Occlusion Therapy to Non-vitamin K Antagonist Oral Anticoagulants
Clinical Trial of Atrial Fibrillation Patients Comparing Left Atrial Appendage Occlusion Therapy to Non-vitamin K Antagonist Oral Anticoagulants
Enrollment Status: Recruiting
Publish Date: February 27, 2025
Intervention Type: Device, Drug
Study Phase: Not Applicable
BAROSTIM THERAPY ™ in Heart Failure With Preserved Ejection Fraction: A Post-Market Registry With the CE-Marked BAROSTIM NEO™ System
BAROSTIM THERAPY ™ in Heart Failure With Preserved Ejection Fraction: A Post-Market Registry With the CE-Marked BAROSTIM NEO™ System
Enrollment Status: Unknown
Publish Date: April 20, 2023
Intervention Type: Device
BAROSTIM THERAPY™ in Heart Failure With Reduced Ejection Fraction: A Post-Market Registry With the CE-Marked BAROSTIM NEO™ System
BAROSTIM THERAPY™ in Heart Failure With Reduced Ejection Fraction: A Post-Market Registry With the CE-Marked BAROSTIM NEO™ System
Enrollment Status: Unknown
Publish Date: April 20, 2023
Intervention Type: Device
BAROSTIM THERAPY™ In Resistant Hypertension: A Post-Market Registry With the CE-Marked BAROSTIM NEO™ System
BAROSTIM THERAPY™ In Resistant Hypertension: A Post-Market Registry With the CE-Marked BAROSTIM NEO™ System
Enrollment Status: Unknown
Publish Date: April 20, 2023
Intervention Type: Device
Assessment of Pacing Stimulus Conduction and Latency Measurements in CRT-D Patients
Assessment of Pacing Stimulus Conduction and Latency Measurements in CRT-D Patients
Enrollment Status: Terminated
Publish Date: November 28, 2018
Intervention Type: Device
Study Phase: Not Applicable
View 4 Less Clinical Trials

48 Total Publications

Conduction system pacing (CSP) for every patient? : Should CSP replace classical right ventricular and biventricular stimulation?
Conduction system pacing (CSP) for every patient? : Should CSP replace classical right ventricular and biventricular stimulation?
Journal: Herz
Published: October 07, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Schmitt's expertise for a condition
ConditionClose
      View All 18 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile